Using a metastatic model of B16 melanoma in the brain and other peripheral sites, Jackson et al., found that CNS melanomas were found to be more tolerogenic than similarly sized tumors outside the CNS due to dysfunctional tumor-specific T cells, and this occurred secondary to an increase in TGF-β secretion from microglia [58]. The gene discussed is TGFB1; the disease is neoplasm.